Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 682,644 | -363,295 | -626,604 | -559,017 | -523,901 |
| Depreciation Amortization | 22,012 | 223,880 | 454,063 | 165,834 | 71,281 |
| Income taxes - deferred | -3 | -55,912 | -46,930 | -34,276 | 377 |
| Accounts receivable | -10,151 | 1,732 | -1,539 | -48,468 | -44,991 |
| Other Working Capital | -52,564 | 100,743 | -4,003 | -94,935 | -23,788 |
| Other Operating Activity | 69,258 | -14,836 | 66,595 | 214,208 | 269,690 |
| Operating Cash Flow | $711,196 | $-107,688 | $-158,418 | $-356,654 | $-251,332 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -508,414 | -248 | -17,720 | 465,428 | 304,613 |
| PPE Investments | -8,790 | 21,554 | -28,438 | -32,016 | -28,213 |
| Net Acquisitions | -291,152 | -67,747 | -92,181 | N/A | -57,118 |
| Purchase Of Investment | -53,628 | -59,377 | -38,398 | -22,787 | -100 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -120,444 | N/A |
| Other Investing Activity | 0 | 150,000 | 0 | -120,444 | 0 |
| Investing Cash Flow | $-861,984 | $44,182 | $-176,737 | $290,181 | $219,182 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 300,000 | N/A |
| Debt Repayment | -1,611 | -1,490 | -301,379 | -151,276 | -2,224 |
| Common Stock Issued | 99,046 | 33,764 | 29,994 | 71,082 | 23,101 |
| Other Financing Activity | 233,659 | 223,592 | 917,785 | -51,854 | 0 |
| Financing Cash Flow | $331,094 | $255,866 | $646,400 | $167,952 | $20,877 |
| Exchange Rate Effect | 22,712 | -7,328 | 3,114 | -2,772 | -7,821 |
| Beginning Cash Position | 795,316 | 610,284 | 295,925 | 197,218 | 216,312 |
| End Cash Position | 998,334 | 795,316 | 610,284 | 295,925 | 197,218 |
| Net Cash Flow | $203,018 | $185,032 | $314,359 | $98,707 | $-19,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | 711,196 | -107,688 | -158,418 | -356,654 | -251,332 |
| Capital Expenditure | -8,860 | -6,502 | -28,438 | -32,016 | -28,213 |
| Free Cash Flow | 702,336 | -114,190 | -186,856 | -388,670 | -279,545 |